Postprandial Effects of Bean and Whole Grain Consumption on Arterial Stiffness
NCT ID: NCT05818358
Last Updated: 2025-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2023-04-01
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Canned Beans of Multiple Varieties in Daily Amounts of 1 Cup and 1/2 Cup on Serum LDL Cholesterol and Other Cardiovascular Disease Risk Biomarkers in Adults With Elevated LDL Cholesterol
NCT03830970
Glycemic Response of Whole Beans and Bean Products
NCT06630312
Exploring the Health Benefits Associated With Daily Pulse Consumption in Individuals With Peripheral Arterial Disease
NCT00755677
Acute Vascular Response To Meals Varying In Glycemic Index And Glycemic Load
NCT01883700
Effect of Consuming Beans for One Month on Blood Lipids, Satiety, Intake Regulation and Body Weight
NCT00741923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Recruitment will consist of a total of 10 participants with arterial stiffness. Participants will be recruited through advertisement from the local community.
The study will be conducted at the Asper Clinical Research Institute, St. Boniface Hospital. Participants will be asked to provide written informed consent prior to participation in the study. Participants who have provided written consent will be asked to attend an in-patient screening visit to provide a fasting blood sample (and females a urine sample) and assess the presence of arterial stiffness (by PWV) to determine eligibility. Should the participant be eligible to participate, they will be scheduled for three study visits to obtain fasting blood samples and assess postprandial blood vessel function. During the first study visit period, participants will be asked to complete a Food Habits Questionnaire.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Black Beans (cooked)
At one of the three visits, participants will consume a ¾ cup of cooked black beans. Participants will be provided with 100 ml of water with the food, and will be allowed to drink up to another 150 mL of water during the 2 hour test period. The participants will not be blinded to the order and the type of food product they receive at a visit, however, the samples will be assigned a number to ensure the analytical team is blinded to the test product until the end of the study. Should the need to re-administer a test product arise, the participant will receive the test product from the same treatment number again at an extra visit after the original 3 visits have been completed.
black beans
¾ cup of cooked black beans
Whole Wheat Grain (cooked)
At one of the three visits, participants will consume a ¾ cup of cooked whole wheat grain. Participants will be provided with 100 ml of water with the food, and will be allowed to drink up to another 150 mL of water during the 2 hour test period. The participants will not be blinded to the order and the type of food product they receive at a visit, however, the samples will be assigned a number to ensure the analytical team is blinded to the test product until the end of the study. Should the need to re-administer a test product arise, the participant will receive the test product from the same treatment number again at an extra visit after the original 3 visits have been completed.
wheat berries
¾ cup of cooked whole wheat grain
White Rice (cooked)
At one of the three visits, participants will consume a ¾ cup of cooked white rice. Participants will be provided with 100 ml of water with the food, and will be allowed to drink up to another 150 mL of water during the 2 hour test period. The participants will not be blinded to the order and the type of food product they receive at a visit, however, the samples will be assigned a number to ensure the analytical team is blinded to the test product until the end of the study. Should the need to re-administer a test product arise, the participant will receive the test product from the same treatment number again at an extra visit after the original 3 visits have been completed.
white rice
¾ cup of cooked white rice
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
black beans
¾ cup of cooked black beans
wheat berries
¾ cup of cooked whole wheat grain
white rice
¾ cup of cooked white rice
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Brachial-ankle pulse wave velocity \>1400 cm/s on at least one side;
3. Plasma creatinine ≤265 µmol/L;
4. Aspartate aminotransferase \<160 U/L, andalanine aminotransferase \<150 U/L;
5. Glycated hemoglobin ≤6.5%;
6. LDL-cholesterol \<5 mmol/L;
7. Stable regime if taking vitamin and mineral/dietary/herbal supplements for the past 1 month and while participating in the study;
8. Has not donated blood or blood products (e.g. platelets) during the past 2 months and willing to continue doing so while participating in the study;
9. Not participating in another dietary intervention trial for the past month and willing to not start another dietary intervention trial for the duration of this study;
10. Willing to comply with the protocol requirements and procedures;
11. Willing to provide informed consent.
Exclusion Criteria
2. Taking vasoactive medications (e.g., ACE inhibitors, ARBs, AGE-breakers, thiazolidinediones, beta-blockers, statins, insulin, etc.);
3. Blood pressure \>160 mmHg systolic and/or \>100 mmHg diastolic;
4. History of gastrointestinal reactions or allergies to beans, bean flour, wheat, wheat flour, gluten, or rice;
5. Body weight exceeds the capacity of the DEXA (350 lbs);
6. Current (within the past 30 days) bacterial, viral or fungal infection;
7. Bleeding disorder;
8. Amputations of upper or lower extremities on both sides;
9. Any acute medical condition or surgical intervention within the past 3 months;
10. Drug and/or alcohol abuse;
11. Psychological disorder(s);
12. Unable to fast overnight;
13. Unable to take prescribed medication without food;
14. Unable to obtain vascular function measurements and/or blood sample at the screening or first study visits;
15. Not fully vaccinated for COVID-19.
45 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Manitoba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Peter Zahradka
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asper Clinical Research Institute
Winnipeg, Manitoba, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zahradka P, Perera D, Charney J, Taylor CG. Distinct Effects of Wheat and Black Bean Consumption on Postprandial Vascular Responses in People with Arterial Stiffness: A Pilot Randomized Cross-Over Study. Nutrients. 2025 Mar 27;17(7):1159. doi: 10.3390/nu17071159.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS25221
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.